Farallon Capital Management Portfolio
Farallon Capital Management 13F filer (CIK 0000909661).
Q2 2026 · 86 positions · Total reported value $21.54B · Top-10 concentration 62.5%
Turnover: 77.8% · 21 new · 23 cut · 103 exited
Active Share (vs S&P 500): 91.2% · vs QQQ: 92.7% — share of the book that differs from index weights (higher = more active) · ranking
In its Q2 2026 13F filing, Farallon Capital Management disclosed 86 equity positions with a combined reported value of $21.54B. The filing implies a focused portfolio: its ten largest positions account for 62.5% of reported value. HoldingsHub classifies the profile as Large / Focused / Health Tilt / High Turnover.
The largest disclosed positions as of Q2 2026 were SPY ($4.48B), RVMD ($2.54B), EA ($1.62B). By sector, the heaviest allocations are Health Care 51.2%, Technology 6.7%. Versus the prior quarter, allocation shifted toward Other (+27.0pp) and away from Health Care (-0.6pp), Industrials (-2.0pp).
Versus the prior quarter, Farallon Capital Management opened 21 new positions, trimmed 23 and fully exited 103, a turnover rate of 77.8% of positions. The portfolio's overlap with the prior quarter was 34% of names.
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
Sector Allocation
| # | Symbol | Company | Shares | Value | Weight | Change |
|---|---|---|---|---|---|---|
| 1 | SPY | STATE STR SPDR S&P 500 ETF T | 6.00M | $4.48B | 20.80% | New |
| 2 | RVMD | REVOLUTION MEDICINES INC | 13.55M | $2.54B | 11.78% | Hold |
| 3 | EA | ELECTRONIC ARTS INC | 7.92M | $1.62B | 7.54% | New |
| 4 | BBIO | BRIDGEBIO PHARMA INC | 10.74M | $800.14M | 3.71% | Add |
| 5 | PTGX | PROTAGONIST THERAPEUTICS INC | 6.35M | $778.25M | 3.61% | Hold |
| 6 | EXEL | EXELIXIS INC | 13.47M | $732.79M | 3.40% | Add |
| 7 | LQDA | LIQUIDIA CORPORATION | 8.37M | $666.94M | 3.10% | Reduce |
| 8 | AMZN | AMAZON COM INC | 2.63M | $627.55M | 2.91% | Reduce |
| 9 | LNTH | LANTHEUS HLDGS INC | 5.58M | $619.43M | 2.88% | Hold |
| 10 | NTRA | NATERA INC | 2.22M | $602.18M | 2.80% | Reduce |
| 11 | UNH | UNITEDHEALTH GROUP INCORPORATED | 1.27M | $528.07M | 2.45% | Reduce |
| 12 | TMO | THERMO FISHER SCIENTIFIC INC | 1.05M | $526.02M | 2.44% | Add |
| 13 | ROIV | ROIVANT SCIENCES LTD | 14.31M | $506.40M | 2.35% | Add |
| 14 | AON | AON PLC | 1.38M | $458.58M | 2.13% | Reduce |
| 15 | BSX | BOSTON SCIENTIFIC CORP | 10.52M | $449.04M | 2.08% | Add |
| 16 | AVGO | BROADCOM INC | 1.15M | $435.09M | 2.02% | Reduce |
| 17 | MSFT | MICROSOFT CORP | 1.11M | $415.12M | 1.93% | Reduce |
| 18 | TNGX | TANGO THERAPEUTICS INC | 12.28M | $383.78M | 1.78% | Add |
| 19 | KKR | KKR & CO INC | 4.12M | $377.98M | 1.75% | Reduce |
| 20 | SNPS | SYNOPSYS INC | 829.60K | $370.06M | 1.72% | Reduce |
| 21 | BEAM | BEAM THERAPEUTICS INC | 10.24M | $351.31M | 1.63% | Add |
| 22 | CRNX | CRINETICS PHARMACEUTICALS IN | 8.99M | $336.37M | 1.56% | Add |
| 23 | GRAL | GRAIL INC | 4.16M | $284.11M | 1.32% | Add |
| 24 | WAB | WABTEC | 894.50K | $241.16M | 1.12% | Reduce |
| 25 | IMVT | IMMUNOVANT INC | 5.80M | $223.67M | 1.04% | Add |
| 26 | TWST | TWIST BIOSCIENCE CORP | 2.14M | $219.79M | 1.02% | Add |
| 27 | AGIO | AGIOS PHARMACEUTICALS INC | 5.92M | $219.59M | 1.02% | Add |
| 28 | ARMK | ARAMARK | 3.63M | $206.30M | 0.96% | Reduce |
| 29 | BIDU | BAIDU INC | 1.20M | $137.58M | 0.64% | Add |
| 30 | NVO | NOVO-NORDISK A S | 2.62M | $125.55M | 0.58% | Add |
| 31 | ACHC | ACADIA HEALTHCARE COMPANY IN | 4.22M | $124.64M | 0.58% | Add |
| 32 | BTSG | BRIGHTSPRING HEALTH SVCS INC | 1.73M | $120.85M | 0.56% | Add |
| 33 | AZN | ASTRAZENECA PLC | 574.00K | $108.84M | 0.51% | Add |
| 34 | JNJ | JOHNSON & JOHNSON | 408.00K | $103.62M | 0.48% | Add |
| 35 | SOXX | ISHARES TR | 130.00K | $83.30M | 0.39% | New |
| 36 | PBLS | PARABILIS MEDICINES INC | 2.37M | $64.82M | 0.30% | New |
| 37 | NVS | NOVARTIS AG | 363.00K | $56.89M | 0.26% | New |
| 38 | GH | GUARDANT HEALTH INC | 322.20K | $48.34M | 0.22% | Add |
| 39 | AVTX | AVALO THERAPEUTICS INC | 2.50M | $46.16M | 0.21% | Add |
| 40 | JOYY | JOYY INC | 699.20K | $46.14M | 0.21% | Add |
| 41 | ASMB | ASSEMBLY BIOSCIENCES INC | 1.60M | $44.09M | 0.20% | Add |
| 42 | ENTA | ENANTA PHARMACEUTICALS INC | 2.42M | $35.26M | 0.16% | Reduce |
| 43 | MAZE | MAZE THERAPEUTICS INC | 1.11M | $33.06M | 0.15% | Add |
| 44 | CGON | CG ONCOLOGY INC | 400.00K | $28.42M | 0.13% | Add |
| 45 | MRK | MERCK & CO INC | 199.00K | $25.57M | 0.12% | Reduce |
| 46 | WRBY | WARBY PARKER INC | 828.00K | $25.12M | 0.12% | New |
| 47 | PCSC | PERCEPTIVE CAP SOLUTIONS COR | 2.25M | $24.48M | 0.11% | Hold |
| 48 | KLRA | KAILERA THERAPEUTICS INC | 1.10M | $24.23M | 0.11% | New |
| 49 | RIO | RIO TINTO PLC | 183.47K | $17.42M | 0.08% | Add |
| 50 | AXTA | AXALTA COATING SYS LTD | 478.00K | $16.36M | 0.08% | New |